Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Latin American Examiner.
Press releases published on June 11, 2025
ZA Miner Launches Global Access to AI-Powered Cloud Mining with $100 Welcome Credit for New Users
GlobeNewswire
·
June 11, 2025
London, UK, June 11, 2025 (GLOBE NEWSWIRE) -- As retail investors increasingly seek reliable, hands-free opportunities in the digital economy, ZA Miner, a next-generation cloud mining platform powered by artificial intelligence and renewable energy, has …
More Lithium Bearing Intersections on Globex’s Lac Escale Royalty Claims
GlobeNewswire
·
June 11, 2025
ROUYN-NORANDA, Quebec, June 11, 2025 (GLOBE NEWSWIRE) -- GLOBEX MINING ENTERPRISES INC. (GMX – Toronto Stock Exchange, G1MN – Frankfurt, Stuttgart, Berlin, Munich, Tradegate, Lang …
De nouvelles intersections de lithium sur les claims à redevance Lac Escale de Globex
GlobeNewswire
·
June 11, 2025
ROUYN-NORANDA, Québec, 11 juin 2025 (GLOBE NEWSWIRE) -- ENTREPRISES MINIÈRES GLOBEX INC. (GMX – Bourse de Toronto, G1MN – Bourses de Francfort, Stuttgart, Berlin, Munich, Tradegate, Lang …
Cabaletta Bio Announces Pricing of Public Offering of Securities
GlobeNewswire
·
June 11, 2025
PHILADELPHIA, June 11, 2025 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (“Cabaletta” or the “Company”) (Nasdaq: CABA), a clinical-stage biotechnology company focused on developing and launching the first curative targeted cell therapies designed specifically …
Aya Gold and Silver Announces Upsize of Previously Announced Bought Deal to $125 Million
GlobeNewswire
·
June 11, 2025
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. The base shelf prospectus is accessible, and the prospectus supplement and any amendment to the foregoing documents will be accessible within one business …
Fate Therapeutics Announces Updated Clinical Data for FT819 Off-the-shelf CAR T-cell Product Candidate Demonstrating Durability of Drug-free Remission for Severe Lupus Nephritis at EULAR 2025 Congress
GlobeNewswire
·
June 11, 2025
All three patients treated with FT819 following fludarabine-free conditioning regimen for severe lupus nephritis achieve Primary Efficacy Renal Response (PERR); first patient to reach 1-year follow-up continues in drug-free Definition of Remission in SLE ( …
Silo Pharma Secures Biomarker Patent for Novel PTSD Therapeutic SPC-15 as Clinical Trial Nears
GlobeNewswire
·
June 11, 2025
SARASOTA, FL, June 11, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on novel therapeutics and drug delivery systems, today announced that the U.S. Patent and …
Veru to Participate in the Virtual BTIG Obesity Health Forum
GlobeNewswire
·
June 11, 2025
MIAMI, FL, June 11, 2025 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory diseases, today announced the company …
Lisata Therapeutics to Present at the 2025 BIO International Convention
GlobeNewswire
·
June 11, 2025
BASKING RIDGE, N.J., June 11, 2025 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata” or the “Company”), a clinical-stage pharmaceutical company developing innovative therapies for the treatment of advanced solid tumors and other …
OKYO Pharma to Present at the Bio International Convention
GlobeNewswire
·
June 11, 2025
LONDON and NEW YORK, June 11, 2025 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative therapies for the treatment of neuropathic corneal pain, a severe ocular condition without an FDA …
Tempest Announces $4.6 Million Registered Direct Offering of Common Stock
GlobeNewswire
·
June 11, 2025
BRISBANE, Calif., June 11, 2025 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company with a pipeline of first-in-class1 targeted and immune-mediated therapeutics to fight cancer, today announced that it has …
FS-Elliott Expands Manufacturing & Service Programs to Maximize Customer Uptime
EIN Presswire
·
June 11, 2025
Accelerated Repairs, On-Demand Storage, and Smarter Manufacturing to Keep Operations Running EXPORT, PA, UNITED STATES, June 10, 2025 /EINPresswire.com/ -- FS-Elliott, a leading manufacturer of centrifugal air and gas compressors, announces a series of …
Cogent Biosciences Secures up to $400 Million in Non-Dilutive Financing
GlobeNewswire
·
June 11, 2025
Facility provides additional funding for next steps of the Company’s growth, including the expected launch of bezuclastinib in 2026 On track to report results from three pivotal trials this year, beginning with SUMMIT results in July WALTHAM, Mass. and …
Vaxart Reports Positive Clinical Data Demonstrating that its Second-Generation Vaccine Technology Produces Much Stronger Antibody Responses than its First-Generation Technology
GlobeNewswire
·
June 11, 2025
- Second-generation norovirus constructs produce statistically significant increases in GI.1 and GII.4 norovirus blocking antibodies (141% and 94%, respectively) compared with first-generation constructs, supporting potential for improved protection …
Ligand Announces 2025 Investor Day in New York City
GlobeNewswire
·
June 11, 2025
JUPITER, Fla., June 11, 2025 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that it will host an Investor Day in New York City on Tuesday, December 9, 2025 at 10 a.m. Eastern Time at the Harvard Club. The event will …
Corvus Pharmaceuticals Presents Soquelitinib Preclinical Data Highlighting Potential of ITK inhibition to Treat Systemic Sclerosis at EULAR 2025 Congress
GlobeNewswire
·
June 11, 2025
SOUTH SAN FRANCISCO, Calif., June 11, 2025 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today announced preclinical data highlighting the potential of soquelitinib to treat systemic sclerosis …
Telix Launches New Prostate Cancer Imaging Agent, Gozellix, in U.S.
GlobeNewswire
·
June 11, 2025
MELBOURNE, Australia and INDIANAPOLIS, June 11, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”, “the Company”) today announces that its next-generation PSMA-PET imaging1 agent for prostate cancer, Gozellix® (kit for …
Bitget Protection Fund Surges over 140% Since Inception Hits All Time High of $725M
GlobeNewswire
·
June 11, 2025
VICTORIA, Seychelles, June 11, 2025 (GLOBE NEWSWIRE) -- Bitget, the leading cryptocurrency exchange and Web3 company, has released a May 2025 report for its user security fund called the Protection Fund, which hit a new peak valuation of $725.1 million in …
Cabaletta Bio Announces Proposed Public Offering of Securities
GlobeNewswire
·
June 11, 2025
PHILADELPHIA, June 11, 2025 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (“Cabaletta” or the “Company”) (Nasdaq: CABA), a clinical-stage biotechnology company focused on developing and launching the first curative targeted cell therapies designed specifically …
Bitget Wallet Taps Hana to Boost Social Finance With 680K HANA Rewards
GlobeNewswire
·
June 11, 2025
SAN SALVADOR, El Salvador, June 11, 2025 (GLOBE NEWSWIRE) -- Bitget Wallet, the leading non-custodial crypto wallet, is working with Hana Network on a new initiative aimed at expanding access to crypto through lightweight, socially-driven user experiences. …